Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.
Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...
Weight-loss drugs: A game changer for India’s top pharma companies
Unless you’ve been living under a rock, you know that weight-loss drugs are the talk of the town. GLP-1 drugs, in particular, ...
Competition will make weight-loss drugs better, cheaper and bigger
Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...
24/7 Wall St20h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Zacks.com on MSN21h
NVO Stock Plunges as Obesity Drug CagriSema Misses Target in Phase III
Novo Nordisk stock slumps as the 22.7% weight loss achieved with its next-gen obesity candidate, CagriSema, in a phase III ...
KOMU17h
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
The study met its main goal, but those watching closely had hoped for an average result of at least 25% weight loss.
We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
STORY: Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March ...
Becker's Hospital Review21h
FDA approves Zepbound for obstructive sleep apnea
Discover the first FDA-approved weight loss medication for obstructive sleep apnea, Zepbound by Eli Lilly. Learn how it can reduce apnea events and CPAP market.